Abstract
Achromobacter xylosoxidans is a Gram-negative aerobic opportunistic bacterium, belonging to the order of Burkholderiales, that can cause infections of virtually all body districts in patients with underlying diseases. However, A. xylosoxidans has rarely been associated with infective endocarditis. The treatment of A. xylosoxidans infections is complicated by both intrinsic and acquired resistance. Here we report on a case of aortic endocarditis by A. xylosoxidans in a Non-Hodgkin lymphoma patient treated with a combination of cefiderocol and other antibiotics, and summarize the available literature.
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference33 articles.
1. Achromobacter infections and treatment options;Antimicrob. Agents Chemother.,2020
2. Mitral endocarditis caused by Achromobacter xylosoxidans in an older patient: Case report and literature review;IDCases,2022
3. (2022, August 18). EUCAST. Available online: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Expert_Rules/2022/Expected_Resistant_Phenotypes_v1.1_20220325.pdf.
4. Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: Antimicrobial resistance and therapeutic strategies;Semin. Respir. Crit. Care Med.,2015
5. Outbreak of Achromobacter xylosoxidans in an Italian cystic fibrosis center: Genome variability, biofilm production, antibiotic resistance, and motility in isolated strains;Front. Microbiol.,2014
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献